Hanson Wade的动态

What an exciting and energising PI Forum! How can we drive to reduce drug therapy costs and meet sustainability targets? Our industry certainly agrees that PI is in part the answer. Join the conversation! #sartorius #processintensification #innovation

In the era of precision medicine, where #CAR-T cells and #gene therapies are transforming healthcare, the need for integrated lab-clinic spaces has never been greater. Vishal Goel shares insights on how these facilities, are crucial for advancing #personalized #therapies and improving patient outcomes. Curious to know why and how this integration is driving innovation? Read the full article to explore the possibilities. #lifesciences #lifescienceindustry #biopharma #biologics #celltherapy #cellandgenetherapy #Tcells #cancer #CARTtherapies #precisionmedicine #researchanddevelopment #manufacturing #oncology #labspace #leasing #India https://lnkd.in/g9vmAwpW

?? Spotlight on the Minimal Residual Disease (MRD) Market! ?? Explore DelveInsight Business Research LLP's latest report on the Minimal Residual Disease Market, providing an in-depth analysis of market trends, growth drivers, emerging therapies, and key players. The leading #MinimalResidualDiseaseCompanies such as Adaptive Biotechnologies Corp., Foresight Diagnostics, Cergentis B.V., ICON plc, 3B BlacBio Biotech, EntroGen, Inc., Quest Diagnostics, Hangzhou ImmuQuad(艾沐蒽) Biotech, LLC., Foresight Diagnostics, Solvias NL (formerly Cergentis) B.V., Natera, Invivoscribe Inc., Idylla Technology, and others. Stay ahead with the latest insights into this evolving market! Get More Insights @ https://lnkd.in/dePGiTRc #MinimalResidualDisease #HealthcareInnovation #OncologyMarket #MarketInsights #DelveInsight

Happy New Year from the EmergentMedTech family! Year 2025 continues to be the year of empowerment for providers who own a NeoGen PSR through an EmergentMedTech partnership. We empower our providers by delivering: Unmatched Training and Support: Free quarterl advanced training programs and ongoing mentorship to ensure confidence and mastery in NeoGen PSR technology. Regenerative Innovations: Integrating cutting-edge approaches with advanced cell/tissue products and biologics to elevate patient outcomes. Business Growth Resources: Proven strategies to drive practice profitability, marketing support to boost visibility, and tools to maximize ROI. Community Connection: A collaborative network of like-minded professionals to share insights, successes, and breakthroughs. Let’s make 2025 another transformative year together! #emergentmedtech #neogen #plasma #aesthetics

?????? ???????????????????????? ???????????????????? ???????????????????? ???? ????????! In 1998, the approval of Herceptin marked a pivotal moment in the life sciences industry, ushering in the era of personalized medicine. By leveraging molecular diagnostics, Herceptin ensured that only those who could benefit received treatment. Fast forward to today, and the integration of companion diagnostics and ?????????????????? ???????????????? ?????????????? (??????)? assessments is transforming patient care. For life sciences organizations, this revolution means rethinking strategies to accelerate product introductions and enhance manufacturing processes. Embracing real-time data capture and operational analysis tools is essential for compliance and efficiency. Christian Berg ???????? ???????????????? ?????????????????? ?????????????????? ????????????????????, Emerson? ?? ???????? ???????? ?????????? ?????? ???????????????????????? ?????? ?????? ???????? ????????????????: https://lnkd.in/gYthPzTf ?????????? ???????????? ?????????? ????????: https://lnkd.in/dxkGndFf #personalizedhealthcare #lifesciences #innovation #healthcarerevolution #moleculardiagnostics #mrd #biotech #pharmaceuticals #healthcaretechnology #genomics #targetedtherapies #datadriven #gmp #manufacturing #patientcare

Excited for the 7th Alcor Drug Discovery Platform Summit under the esteemed leadership of our Chairman for Day 1,?Abdulkader Rahmo, who serves as President & CSO?SMSbiotech. As we convene for this premier event, we embark on a collective journey of exploration, collaboration, and innovation in the dynamic realm of drug discovery. Under Chairman Rahmo's visionary guidance, this summit promises to be a nexus of cutting-edge research, insightful discussions, and invaluable networking opportunities. Join us as we unite with leading experts, industry pioneers, and visionaries to chart the course for the future of drug discovery. This summit isn't just about presentations—it's a convergence of minds dedicated to driving progress, shaping the future, and making a meaningful impact on global health. Let's elevate the discourse, ignite innovation, and propel the field of drug discovery to new heights. Together, we're shaping a healthier, brighter tomorrow. #AlcorDrugDiscovery?#Summit?#Innovation?#ADDP2024 #DrugDiscovery #Preclinical #LifeSciencesSummits #DrugDiscovery #PreclinicalSummits #USADrugDiscoverySummits

Been using different tools including to generate ideas for a review article. A infographic was proposed and I tried it out. Please let me know what you think and ideally please share your infographics. "Importance of drug delivery in drug discovery and development" "Here is a clean and modern infographic highlighting the importance of drug delivery in drug discovery and development. The design focuses on simplicity and clarity, making it suitable for professional and scientific audiences." Separately, an actual review article. Will share some figures from the article. All rights belong to the authors. "Autonomous dose regulation and enabling several doses to be mimicked with a single administration" Baryakova, Tsvetelina H. et al. "The next generation of systems have the potential to instate an even more radical paradigm shift by, for example, permitting oral delivery of biomacromolecules, allowing for autonomous dose regulation and enabling several doses to be mimicked with a single administration." from Baryakova, Tsvetelina H., Brett H. Pogostin, Robert Langer, and Kevin J. McHugh. "Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems."?Nature Reviews Drug Discovery?22, no. 5 (2023): 387-409. #drugdelivery

#GenerationHealthSpeaks with Maria Loureiro and Daniel M. Vasconcelos on why Pharma research often fails to reach patients. Maria highlights the consequences of uncommercialized research, while Daniel explains key pitfalls: unmet clinical needs, team instability, and the need for trust and long-term structures. How can we overcome these challenges? #GenerationHealthSpeaks #PharmaInnovation #BiotechImpact #TheGenH Daniel Guedelha

Are you interested in networking with peers and learning about #DrugDevelopment? There's STILL TIME to sign up for the BENELUX Drug Development Symposium 2.0 happening in Utrecht on 28 Nov. 2024. Where? Accelerator, Uppsalalaan 17, Utrecht Science Park, Netherlands Register here: https://gag.gl/4YjTnB Gain fresh perspectives on pitching to investors, hear insights from biotech leaders on drug development, AI in clinical trials, and explore the role of innovation and technology in sustainability and global health equity. #biotech #innovation #clinicaltrials #healthequity #sustainability

What a profound and compelling endorsement for fuzing biotechnology, care management, virtual medicine, clinical trial data collection, and the future of achieving better quaulity in the country that exceeds all others in spending but is seeing rapidly shortening average life expectancy. https://lnkd.in/gsQqxvm4